These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

436 related articles for article (PubMed ID: 17996559)

  • 21. [Abnormality of HDL subfractions in cholesteryl ester transfer protein deficiency].
    Miida T; Inano K; Nakamura Y; Matsuto T; Hoshiyama M; Kaneko K; Okada M
    Rinsho Byori; 1996 Sep; 44(9):865-70. PubMed ID: 8911072
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The cholesteryl ester transfer protein (CETP) TaqIB polymorphism in the cholesterol and recurrent events study: no interaction with the response to pravastatin therapy and no effects on cardiovascular outcome: a prospective analysis of the CETP TaqIB polymorphism on cardiovascular outcome and interaction with cholesterol-lowering therapy.
    de Grooth GJ; Zerba KE; Huang SP; Tsuchihashi Z; Kirchgessner T; Belder R; Vishnupad P; Hu B; Klerkx AH; Zwinderman AH; Jukema JW; Sacks FM; Kastelein JJ; Kuivenhoven JA
    J Am Coll Cardiol; 2004 Mar; 43(5):854-7. PubMed ID: 14998629
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Plasma lipoprotein composition and cholesteryl ester transfer from high density lipoproteins to very low density and low density lipoproteins in patients with non-insulin-dependent diabetes mellitus.
    Bhatnagar D; Durrington PN; Kumar S; Mackness MI; Boulton AJ
    Diabet Med; 1996 Feb; 13(2):139-44. PubMed ID: 8641118
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Variation in the cholesteryl ester transfer protein (CETP) gene does not influence individual plasma cholesterol response to changes in the nature of dietary fat.
    Aitken WA; Chisholm AW; Duncan AW; Harper MJ; Humphries SE; Mann JI; Murray Skeaff C; Sutherland WH; Wallace AJ; Williams SM
    Nutr Metab Cardiovasc Dis; 2006 Jul; 16(5):353-63. PubMed ID: 16829344
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Raising high-density lipoprotein with cholesteryl ester transfer protein inhibitors.
    Clark RW
    Curr Opin Pharmacol; 2006 Apr; 6(2):162-8. PubMed ID: 16487747
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cholesteryl ester transfer protein directly mediates selective uptake of high density lipoprotein cholesteryl esters by the liver.
    Gauthier A; Lau P; Zha X; Milne R; McPherson R
    Arterioscler Thromb Vasc Biol; 2005 Oct; 25(10):2177-84. PubMed ID: 16123327
    [TBL] [Abstract][Full Text] [Related]  

  • 27. High plasma cholesteryl ester transfer but not CETP mass predicts incident cardiovascular disease: a nested case-control study.
    Kappelle PJ; Perton F; Hillege HL; Dallinga-Thie GM; Dullaart RP
    Atherosclerosis; 2011 Jul; 217(1):249-52. PubMed ID: 21524747
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Lipoproteins and CETP levels as risk factors for severe sepsis in hospitalized patients.
    Grion CM; Cardoso LT; Perazolo TF; Garcia AS; Barbosa DS; Morimoto HK; Matsuo T; Carrilho AJ
    Eur J Clin Invest; 2010 Apr; 40(4):330-8. PubMed ID: 20486994
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhibition of cholesteryl ester transfer protein activity by JTT-705 increases apolipoprotein E-containing high-density lipoprotein and favorably affects the function and enzyme composition of high-density lipoprotein in rabbits.
    Zhang B; Fan P; Shimoji E; Xu H; Takeuchi K; Bian C; Saku K
    Arterioscler Thromb Vasc Biol; 2004 Oct; 24(10):1910-5. PubMed ID: 15331428
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relationship of endogenous hyperleptinemia to serum paraoxonase 1, cholesteryl ester transfer protein, and lecithin cholesterol acyltransferase in obese individuals.
    Bajnok L; Seres I; Varga Z; Jeges S; Peti A; Karanyi Z; Juhasz A; Csongradi E; Mezosi E; Nagy EV; Paragh G
    Metabolism; 2007 Nov; 56(11):1542-9. PubMed ID: 17950106
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Plasma cholesteryl ester transfer, but not cholesterol esterification, is related to lipoprotein-associated phospholipase A2: possible contribution to an atherogenic lipoprotein profile.
    Dullaart RP; Constantinides A; Perton FG; van Leeuwen JJ; van Pelt JL; de Vries R; van Tol A
    J Clin Endocrinol Metab; 2011 Apr; 96(4):1077-84. PubMed ID: 21252249
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Cholesteryl ester transfer protein decreases high-density lipoprotein and severely aggravates atherosclerosis in APOE*3-Leiden mice.
    Westerterp M; van der Hoogt CC; de Haan W; Offerman EH; Dallinga-Thie GM; Jukema JW; Havekes LM; Rensen PC
    Arterioscler Thromb Vasc Biol; 2006 Nov; 26(11):2552-9. PubMed ID: 16946130
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Atorvastatin effect on the distribution of high-density lipoprotein subfractions and human paraoxonase activity.
    Harangi M; Mirdamadi HZ; Seres I; Sztanek F; Molnár M; Kassai A; Derdák Z; Illyés L; Paragh G
    Transl Res; 2009 Apr; 153(4):190-8. PubMed ID: 19304278
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Advances on the research of the relationship between cholesteryl ester transfer protein and atherosclerosis].
    Huang ZY; Guo HW
    Wei Sheng Yan Jiu; 2005 Nov; 34(6):765-7. PubMed ID: 16535859
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Efficacy and safety of torcetrapib, a novel cholesteryl ester transfer protein inhibitor, in individuals with below-average high-density lipoprotein cholesterol levels.
    Davidson MH; McKenney JM; Shear CL; Revkin JH
    J Am Coll Cardiol; 2006 Nov; 48(9):1774-81. PubMed ID: 17084249
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Increased large VLDL particles confer elevated cholesteryl ester transfer in diabetes.
    Dullaart RP; de Vries R; Kwakernaak AJ; Perton F; Dallinga-Thie GM
    Eur J Clin Invest; 2015 Jan; 45(1):36-44. PubMed ID: 25402623
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Effects of short-term and long-term danazol treatment on lipoproteins, coagulation, and progression of atherosclerosis: two clinical trials in healthy volunteers and patients with hereditary angioedema.
    Birjmohun RS; Kees Hovingh G; Stroes ES; Hofstra JJ; Dallinga-Thie GM; Meijers JC; Kastelein JJ; Levi M
    Clin Ther; 2008 Dec; 30(12):2314-23. PubMed ID: 19167590
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Higher frequency of abnormal serum angiopoietin-like protein 3 than abnormal cholesteryl ester transfer protein in Japanese hyperalphalipoproteinemic subjects.
    Moon HD; Nakajima K; Kamiyama K; Takanashi K; Sakurabayashi I; Nagamine T
    Clin Chim Acta; 2008 Dec; 398(1-2):99-104. PubMed ID: 18804459
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Cholesterol ester transfer protein. A major player in cholesterol metabolism].
    Hansen PR
    Ugeskr Laeger; 1999 Sep; 161(38):5295-8. PubMed ID: 10536513
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Alterations in composition and concentration of lipoproteins and elevated cholesteryl ester transfer in non-insulin-dependent diabetes mellitus (NIDDM).
    Elchebly M; Porokhov B; Pulcini T; Berthezène F; Ponsin G
    Atherosclerosis; 1996 Jun; 123(1-2):93-101. PubMed ID: 8782840
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 22.